Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1
Top Morning News: Tanzanian Royalty Exploration Corp. (NYSEMKT:TRX), Pfizer Inc. (NYSE:PFE), Finish Line Inc. (NASDAQ:FINL), One Liberty Properties Inc. (NYSE:OLP), Xencor (NASDAQ:XNCR) - Property Mentor Group

Top Morning News: Tanzanian Royalty Exploration Corp. (NYSEMKT:TRX), Pfizer Inc. (NYSE:PFE), Finish Line Inc. (NASDAQ:FINL), One Liberty Properties Inc. (NYSE:OLP), Xencor (NASDAQ:XNCR)


On Dec 09, Tanzanian Royalty Exploration Corporation (NYSEMKT:TRX) announce that it has closed in escrow the issuance of US$10,000,000 in convertible senior notes and up to 3,642,857 common share purchase warrants to an institutional lender. Tanzanian Royalty Exploration Corp. (NYSEMKT:TRX) in last trading activity moved down -23.78% to close at $0.63. Company weekly performance is -15.54% while its quarterly performance stands at -69.51%. Tanzanian Royalty Exploration Corp. (NYSEMKT:TRX) is -77.76% away from its 52 week high.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Pfizer Inc. (NYSE:PFE) has received EU marketing authorization for DUAVIVE® (conjugated estrogens/bazedoxifene (BZA/CE)) from the European Commission. In the EU DUAVIVE™ is indicated for the treatment of estrogen deficiency symptoms in postmenopausal women with a uterus (with at least 12 months since the last menses) for whom treatment with progestin-containing therapy is not appropriate. On last trading day Pfizer Inc. (NYSE:PFE) moved down -0.09% to close at $31.94. Its volatility for the week is 2.08% while volatility for the month is 1.88%. PFE’s sales growth for past 5 years was 1.30% and its EPS growth for past 5 years was 6.80%. Pfizer Inc. (NYSE:PFE) monthly performance is 4.93%.

Athletic shoes and apparel retailer Finish Line, Inc. (NASDAQ:FINL) Friday reported a rise in the third-quarter profit, reflecting higher sales, lower impairment charges and store closing costs, as well as a tax benefit. Earnings per share remained flat with last year. Finish Line Inc. (NASDAQ:FINL) in last trading activity fell -19.20% to close at $23.35. Company weekly performance is -17.55% while its quarterly performance stands at -21.88%. Finish Line Inc. (NASDAQ:FINL) is -26.59% away from its 52 week high.

On Dec 11, One Liberty Properties, Inc. (NYSE:OLP) announced that its Board of Directors has declared a quarterly dividend on the Company’s common stock of $0.39 per share. The dividend is payable January 7, 2015 to stockholders of record on December 29, 2014. The dividend will be included in stockholders’ 2014 taxable income. One Liberty Properties Inc. (NYSE:OLP) has 0.10% insider ownership while its institutional ownership stands at 46.10%. In last trading activity company’s stock closed at $24.09.

Xencor, Inc. (NASDAQ: XNCR), announced that it has entered into a collaboration and licensing agreement with Novo Nordisk to jointly discover novel biologic drug candidates for an undisclosed target by combining multiple Xencor XmAb® technologies, including bispecific and immune inhibitor technologies On Friday shares of Xencor, Inc. (NASDAQ:XNCR) closed at $16.62.


Leave a Reply

Your email address will not be published. Required fields are marked *